[1] |
Członkowska A, Litwin T, Dusek P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4(1): 21.
doi: 10.1038/s41572-018-0018-3
pmid: 30190489
|
[2] |
中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南2021[J]. 中华神经科杂志, 2021, 54(4): 310-319.
|
[3] |
杨兴祥, 江南, 黄仁刚, 等. 慢性乙型肝炎丙氨酸转氨酶低于2倍正常上限者的肝组织学改变[J]. 中华消化杂志, 2011, 31(9): 594-597.
|
[4] |
Cheung KS, Seto WK, Fung J, et al. Epidemiology and natural history of Wilson’s disease in the Chinese: a territory-based study in Hong Kong between 2000 and 2016[J]. World J Gastroenterol, 2017, 23(43): 7716-7726.
doi: 10.3748/wjg.v23.i43.7716
URL
|
[5] |
Zischka H, Lichtmannegger J. Pathological mitochondrial copper overload in livers of Wilson’s disease patients and related animal models[J]. Ann N Y Acad Sci, 2014, 1315: 6-15.
doi: 10.1111/nyas.12347
URL
|
[6] |
Dzieézyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 157-169.
|
[7] |
黄芳, 黄丽, 李洵桦. 角膜K-F环对肝豆状核变性的诊断价值[J]. 中国现代医学杂志. 2013. 23(3): 44-47.
|
[8] |
Oe S, Honma Y, Yabuki K, et al. Importance of a liver biopsy in the management of Wilson disease[J]. Intern Med, 2020, 59(1): 77-81.
doi: 10.2169/internalmedicine.3440-19
URL
|
[9] |
Pfeiffenberger J, Lohse CM, Gotthardt D, et al. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment[J]. J Inherit Metab Dis, 2019, 42(2): 371-380.
doi: 10.1002/jimd.12046
pmid: 30746719
|
[10] |
Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson’s disease[J]. J Clin Neurosci, 2019, 59: 167-174.
doi: S0967-5868(18)30210-8
pmid: 30385165
|
[11] |
Dong Y, Ni W, Chen WJ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson’s disease guides genetic diagnosis[J]. Theranostics, 2016, 6(5): 638-649.
doi: 10.7150/thno.14596
pmid: 27022412
|
[12] |
Møller LB, Ott P, Lund C, et al. Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations[J]. Am J Med Genet A, 2005, 138(4): 340-343.
|
[13] |
Mufti AR, Burstein E, Csomos RA, et al. XIAP is a copper binding protein deregulated in Wilson’s disease and other copper toxicosis disorders[J]. Mol Cell, 2006, 21(6): 775-785.
doi: 10.1016/j.molcel.2006.01.033
URL
|
[14] |
Moreno-Marro S, Barrachina-Bonet L, Páramo-Rodríguez L, et al. Wilson’s disease in Spain: validation of sources of information used by the rare eiseases registries[J]. Gac Sanit, 2020.[Epub ahead of print].
|
[15] |
Svetel M, Pekmezoviéc T, Petroviéc I, et al. Long-term outcome in Serbian patients with Wilson disease[J]. Eur J Neurol, 2009, 16(7): 852-857.
doi: 10.1111/j.1468-1331.2009.02607.x
pmid: 19473354
|
[16] |
Bruha R, Marecek Z, Pospisilova L, et al. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation[J]. Liver Int, 2011, 31(1): 83-91.
doi: 10.1111/j.1478-3231.2010.02354.x
URL
|
[17] |
Alam S, Lal BB, Sood V, et al. AARC-ACLF score: best predictor of outcome in children and adolescents with decompensated Wilson disease[J]. Hepatol Int, 2019, 13(3): 330-338.
doi: 10.1007/s12072-019-09938-3
URL
|
[18] |
Weiss KH, Schäfer M, Gotthardt DN, et al. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease[J]. Clin Transplant, 2013, 27(6): 914-922.
doi: 10.1111/ctr.12259
URL
|
[19] |
Ismail MS, Hassan M, Martinez-Camacho A, et al. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades[J]. Transpl Int, 2020, 33(8): 925-935.
doi: 10.1111/tri.13622
URL
|
[20] |
Li X, Lu Z, Lin Y, et al. Clinical features and mutational analysis in 114 young children with Wilson disease from South China[J]. Am J Med Genet A, 2019, 179(8): 1451-1458.
|